What Is Melanotan II?
TL;DR: Melanotan II is an unapproved tanning peptide that stimulates melanin production and carries a more significant side-effect profile — including FDA warnings and case reports linking it to mole changes — than its better-known derivative, PT-141.
Melanotan II is a synthetic peptide that activates melanocortin receptors throughout the body, most notably MC1R, which triggers melanocytes (pigment-producing skin cells) to produce more melanin. It was originally researched at the University of Arizona in the 1990s as a potential sunless-tanning and skin-cancer-prevention agent, though it was never approved for that or any other use.
How It Works
By broadly activating melanocortin receptors, Melanotan II increases melanin production (causing tanning) while also affecting other melanocortin-receptor-linked systems in the body, including those involved in appetite and sexual arousal — this broad activity is precisely why it produces more side effects than the more targeted PT-141, which was developed later to isolate just the arousal-related pathway.
A Note on Risk
Melanotan II stands out among peptides discussed on this site for having a specific FDA public warning and case reports connecting its use to changes in moles and, in rare cases, melanoma. Anyone considering it — especially with fair skin, many moles, or a personal or family history of skin cancer — should treat this as a materially higher-risk compound and strongly consider discussing it with a dermatologist first.